摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 5-(4-fluorophenyl)-1-(4-methanesulfonylphenyl)-1H-pyrazole-3-carboxylate | 1046152-05-9

中文名称
——
中文别名
——
英文名称
methyl 5-(4-fluorophenyl)-1-(4-methanesulfonylphenyl)-1H-pyrazole-3-carboxylate
英文别名
methyl 5-(4-fluorophenyl)-1-(2-nitrophenyl)-1H-pyrazole-3-carboxylate
methyl 5-(4-fluorophenyl)-1-(4-methanesulfonylphenyl)-1H-pyrazole-3-carboxylate化学式
CAS
1046152-05-9
化学式
C18H15FN2O4S
mdl
——
分子量
374.393
InChiKey
CILHXYGOOSLFIB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.87
  • 重原子数:
    26.0
  • 可旋转键数:
    4.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    78.26
  • 氢给体数:
    0.0
  • 氢受体数:
    6.0

反应信息

  • 作为反应物:
    描述:
    methyl 5-(4-fluorophenyl)-1-(4-methanesulfonylphenyl)-1H-pyrazole-3-carboxylate 在 lithium hydroxide 作用下, 以 四氢呋喃甲醇 为溶剂, 反应 15.0h, 以63%的产率得到5-(4-Fluorophenyl)-1-(4-methylsulfonylphenyl)pyrazole-3-carboxylic acid
    参考文献:
    名称:
    Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 1-(4-methanesulfonylphenyl)-5-aryl-1H-pyrazol-3-carboxylic acids: Synthesis, nitric oxide release studies and anti-inflammatory activities
    摘要:
    A new group of hybrid nitric oxide-releasing anti-inflammatory drugs (NONO-coxibs) wherein an O(2)-acetoxymethyl-1-(N-ethyl-N-methylamino)diazen-1-ium-1,2-diolate (11a-c) NO-donor moiety is attached directly to the carboxylic acid group of 1-(4-methanesulfonylphenyl)-5-aryl-1H-pyrazol-3-carboxylic acids were synthesized. The diazen-1-ium-1,2-diolate compounds 11a-c all released a low amount of NO upon incubation with phosphate buffer (PBS) at pH 7.4 (7.7-9.3% range). In comparison, the percentage of NO released was significantly higher (67.5-73.6% of the theoretical maximal release of two molecules of NO/molecule of the parent hybrid ester prodrug) when the diazen-1-ium-1,2-diolate ester prodrugs were incubated in the presence of rat serum. These incubation studies suggest that both NO and the anti-inflammatory 1-(4-methanesulfonylphenyl)-5-(4-H, 4-F or 4-Me-phenyl)-1H-pyrazol-3- carboxylic acid (9a-c) would be released from the parent NONO-coxib upon in vivo cleavage by non-specific serum esterases. The 1-(4-methanesulfonylphenyl)-5-(4-H, 4-F or 4-Me-phenyl)-1H-pyrazol-3- carboxylic acids (9a-c) exhibited AI activities (ID(50) = 85.2-104.4 mg/kg po range) between that exhibited by the reference drugs aspirin (ID(50) = 128.7 mg/kg po) and celecoxib (ID(50) = 10.8 mg/kg po). Hybrid ester anti-inflammatory/NO-donor prodrugs (NONO-coxibs) offers a potential drug design concept targeted toward the development of anti-inflammatory drugs that are devoid of adverse ulcerogenic and/or cardiovascular effects. (c) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2008.05.028
  • 作为产物:
    参考文献:
    名称:
    Development of 1,5-Diaryl-Pyrazole-3-Formate Analogs as Antifungal Pesticides and Their Application in Controlling Peanut Stem Rot Disease
    摘要:
    图形摘要

    3-氯吡啶基团赋予化合物6与甲基异硫氰酸甲酯和噻嗪酰胺对硬皮病菌的抗真菌作用相当,且呈剂量依赖性。

    DOI:
    10.3389/fmicb.2021.728173
点击查看最新优质反应信息